MBL949

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MBL949, covering 2024-05-31 to 2024-05-31. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess Safety, Tolerability and Efficacy of SC Administered MBL949 in Obese Participants With or Without T2DM [Phase 2]

See pricing